Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 May;34(5):708–712. doi: 10.1136/gut.34.5.708

Fate of oral enzymes in pancreatic insufficiency.

L Guarner 1, R Rodríguez 1, F Guarner 1, J R Malagelada 1
PMCID: PMC1374195  PMID: 8504976

Abstract

Oral pancreatic enzyme supplements, including those protected from gastric acidity by enteric coating, often achieve only partial correction of pancreatic steatorrhoea. To characterise the mechanisms involved in vivo, eight patients with steatorrhoea due to advanced pancreatic insufficiency and nine healthy controls were studied. Two sets of studies (small bowel intubation and five day faecal fat quantification) were randomly performed while patients were either on enteric coated pancreatin or equivalent placebo. A 260 cm long multilumen tube was used for double marker perfusion of two 20 cm segments located in the duodenum and in the ileum respectively. Luminal pH, flow, and trypsin and lipase activity outputs were measured at each segment for four hours postcibally. Placebo treated patients with pancreatic steatorrhoea had low enzyme outputs in the duodenal test segment and even lower outputs in the ileal segment. Pancreatin treatment significantly decreased steatorrhoea (p < 0.05) and increased luminal enzyme outputs (p < 0.05). The increase was much greater in the ileal than in the duodenal segment. Thus enteric coated pancreatin treatment abolished the normal gradient between postcibal duodenal and ileal lipase output. The results suggest that enteric coated pancreatin nearly corrects severe pancreatic steatorrhoea. The ingested lipase was utilised inefficiently, however, as luminal enzyme activity in the ileum was enhanced to a greater extent than in the duodenum, and consequently the absorptive potential of the small bowel was only partially utilised.

Full text

PDF
708

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORGSTROM B., DAHLQVIST A., LUNDH G., SJOVALL J. Studies of intestinal digestion and absorption in the human. J Clin Invest. 1957 Oct;36(10):1521–1536. doi: 10.1172/JCI103549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bousset-Risso M., Bonicel J., Rovery M. Limited proteolysis of porcine pancreatic lipase. Lability of the Phe 335-Ala 336 bond towards chymotrypsin. FEBS Lett. 1985 Mar 25;182(2):323–326. doi: 10.1016/0014-5793(85)80325-2. [DOI] [PubMed] [Google Scholar]
  3. DiMagno E. P., Go V. L., Summerskill W. H. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973 Apr 19;288(16):813–815. doi: 10.1056/NEJM197304192881603. [DOI] [PubMed] [Google Scholar]
  4. DiMagno E. P., Malagelada J. R., Go V. L., Moertel C. G. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med. 1977 Jun 9;296(23):1318–1322. doi: 10.1056/NEJM197706092962304. [DOI] [PubMed] [Google Scholar]
  5. DiMagno E. P., Malagelada J. R., Go V. L. Relationship between alcoholism and pancreatic insufficiency. Ann N Y Acad Sci. 1975 Apr 25;252:200–207. doi: 10.1111/j.1749-6632.1975.tb19157.x. [DOI] [PubMed] [Google Scholar]
  6. Dutta S. K., Rubin J., Harvey J. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology. 1983 Mar;84(3):476–482. [PubMed] [Google Scholar]
  7. Go V. L., Hofmann A. F., Summerskill W. H. Simultaneous measurements of total pancreatic, biliary, and gastric outputs in man using a perfusion technique. Gastroenterology. 1970 Mar;58(3):321–328. [PubMed] [Google Scholar]
  8. Graham D. Y. An enteric-coated pancreatic enzyme preparation that works. Dig Dis Sci. 1979 Dec;24(12):906–909. doi: 10.1007/BF01311943. [DOI] [PubMed] [Google Scholar]
  9. Ihse I., Lilja P., Lundquist I. Intestinal concentrations of pancreatic enzymes following pancreatic replacement therapy. Scand J Gastroenterol. 1980;15(2):137–144. doi: 10.3109/00365528009181445. [DOI] [PubMed] [Google Scholar]
  10. Lamers C. B., Jansen J. B. Omeprazole as adjunct to enzyme replacement in severe pancreatic insufficiency. Br Med J (Clin Res Ed) 1986 Oct 18;293(6553):994–994. doi: 10.1136/bmj.293.6553.994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Layer P., Go V. L., DiMagno E. P. Fate of pancreatic enzymes during small intestinal aboral transit in humans. Am J Physiol. 1986 Oct;251(4 Pt 1):G475–G480. doi: 10.1152/ajpgi.1986.251.4.G475. [DOI] [PubMed] [Google Scholar]
  12. Layer P., Zinsmeister A. R., DiMagno E. P. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology. 1986 Jul;91(1):41–48. doi: 10.1016/0016-5085(86)90436-1. [DOI] [PubMed] [Google Scholar]
  13. Malagelada J. R., Go V. L., Summerskill W. H. Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals. Dig Dis Sci. 1979 Feb;24(2):101–110. doi: 10.1007/BF01324736. [DOI] [PubMed] [Google Scholar]
  14. Malagelada J. R. Quantificantion of gastric solid-liquid discrimination during digestion of ordinary meals. Gastroenterology. 1977 Jun;72(6):1264–1267. [PubMed] [Google Scholar]
  15. Meyer J. H., Elashoff J., Porter-Fink V., Dressman J., Amidon G. L. Human postprandial gastric emptying of 1-3-millimeter spheres. Gastroenterology. 1988 Jun;94(6):1315–1325. doi: 10.1016/0016-5085(88)90669-5. [DOI] [PubMed] [Google Scholar]
  16. Regan P. T., Malagelada J. R., DiMagno E. P., Glanzman S. L., Go V. L. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med. 1977 Oct 20;297(16):854–858. doi: 10.1056/NEJM197710202971603. [DOI] [PubMed] [Google Scholar]
  17. Regan P. T., Malagelada J. R., Dimagno E. P., Go V. L. Rationale for the use of cimetidine in pancreatic insufficiency. Mayo Clin Proc. 1978 Feb;53(2):79–83. [PubMed] [Google Scholar]
  18. Regan P. T., Malagelada J. R., Dimagno E. P., Go V. L. Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: correction by treatment. Gastroenterology. 1979 Aug;77(2):285–289. [PubMed] [Google Scholar]
  19. Thiruvengadam R., DiMagno E. P. Inactivation of human lipase by proteases. Am J Physiol. 1988 Oct;255(4 Pt 1):G476–G481. doi: 10.1152/ajpgi.1988.255.4.G476. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES